Recombinant Human SFN Protein，His

The study of SFN (Sfn, also known as Stratifin or 14-3-3 sigma) recombinant protein has gained significant attention due to its pivotal role in various cellular processes, including cell cycle regulation, apoptosis, and stress response. SFN acts as a key regulator of signaling pathways related to cell growth and differentiation, making it a critical player in the prevention of tumor progression and the maintenance of cellular homeostasis. Its expression is often altered in various cancers, with downregulation associated with tumor development and metastasis. The recombinant production of SFN facilitates detailed studies into its structure-function relationships, allowing researchers to dissect its interactions with other proteins and its mechanistic pathways. Additionally, the therapeutic potential of SFN as a biomarker for cancer diagnosis and prognosis has sparked interest in developing assays and interventions targeting this protein. Understanding the molecular mechanisms underlying SFN's function can provide insights into innovative cancer treatment strategies, with the hope of leveraging its regulatory properties to inhibit tumor growth and enhance the efficacy of existing therapies. Overall, the exploration of SFN recombinant protein not only enhances our understanding of fundamental biological processes but also holds promise for advancements in cancer research and therapeutic development.